Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Plasma metabolomics study reveals the critical metabolic signatures for benzene-induced hematotoxicity
Xiaoli Guo, Lei Zhang, Jingyu Wang, Wei Zhang, Jing Ren, Yujiao Chen, Yanlin Zhang, Ai Gao
Xiaoli Guo, Lei Zhang, Jingyu Wang, Wei Zhang, Jing Ren, Yujiao Chen, Yanlin Zhang, Ai Gao
View: Text | PDF
Research Article Metabolism

Plasma metabolomics study reveals the critical metabolic signatures for benzene-induced hematotoxicity

  • Text
  • PDF
Abstract

Metabolomics has been used to explore the molecular mechanism and screen biomarkers. However, the critical metabolic signatures associated with benzene-induced hematotoxicity remain elusive. Here, we performed a plasma metabolomics study in 86 benzene-exposed workers and 76 healthy controls, followed by a validation analysis in mice, to investigate the dynamical change of the metabolic profile. We found that 8 fatty acids were significantly altered in both benzene-exposed worker and benzene-exposed animal models. These metabolites were significantly associated with S-phenylmercapturic acid and WBC, and they mediated the benzene-induced WBC decline. Furthermore, in vivo results confirm that fatty acid levels were dynamically altered, characterized by a decrease at 15 days and then sharp increases at 30 and 45 days. Following these identified fatty acids, the potential metabolic pathways were investigated. Fatty acids, as precursors for fatty acid oxidation, may disturb the balance of fatty acid biosynthesis and degradation. Our results reveal that fatty acid metabolism was strongly reprogrammed after benzene exposure. This abnormal change of fatty acids might be the key metabolic signature associated with benzene-induced hematotoxicity.

Authors

Xiaoli Guo, Lei Zhang, Jingyu Wang, Wei Zhang, Jing Ren, Yujiao Chen, Yanlin Zhang, Ai Gao

×

Figure 5

Interrupted fatty acid metabolism associated with benzene-induced hematotoxicity.

Options: View larger image (or click on image) Download as PowerPoint
Interrupted fatty acid metabolism associated with benzene-induced hemato...
SAFA, saturated fatty acid (no unsaturated double bonds); MUFA, monounsaturated fatty acid (1 unsaturated double bond); PUFA, polyunsaturated fatty acid (≥2 unsaturated double bonds); C12:0, dodecanoic acid; C14:0, myristic acid; C14:1, myristoleic acid; C16:1, palmitoleic acid; C17:1, 10z-heptadecenoic acid; C18:1, oleic acid; C18:2, linoleic acid; C22:6, DHA; CD36, CD36 molecule; SLC27A1, solute carrier family 27 member 1; FABP1, fatty acid binding protein 1; ACACA, acetyl-CoA carboxylase α; FASN, fatty acid synthase; FADS1, fatty acid desaturase 1; SCD, stearoyl-CoA desaturase; ELOVL5, ELOVL fatty acid elongase 5; CPT1A, carnitine palmitoyltransferase 1A; CPT2, carnitine palmitoyltransferase 2; NADH, nicotinamide adenine dinucleotide; FADH2, flavine adenine dinucleotide, reduced; and ACLY, ATP citrate lyase.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts